Propionic Acid

Propionic Acid

SCHEMBL4171576

CCC(=O)O.O=c1[nH]c2ccccc2c2cc[nH]c12

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.46
PIM3 Q86V86 1/20 0.46
KDM4E B2RXH2 12/20 0.45
TDP1 Q9NUW8 1/20 0.45
ALDH1A1 P00352 7/20 0.45
HSD17B10 Q99714 3/20 0.45
MAPT P10636 3/20 0.45
PARP1 P09874 2/20 0.45
MEN1 O00255 1/20 0.45
TNKS O95271 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
GPR3 P46089 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
KMT2A Q03164 1/20 0.45
PARP15 Q460N3 1/20 0.45
TNKS2 Q9H2K2 1/20 0.45
HPGD P15428 2/20 0.43
RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL4162573 0.92 KDM4E (0.46) PIM1PIM3KDM4ETDP1ALDH1A1
3-Methylbutanoic Acid SCHEMBL4162528 0.87 PIM1 (0.43) PIM1PIM3KDM4ETDP1ALDH1A1
SCHEMBL2552450 0.86 KDM4E (0.59) PIM1PIM3KDM4ETDP1ALDH1A1
SCHEMBL30577488 0.86 KDM4E (0.59) PIM1PIM3KDM4ETDP1ALDH1A1
Propionic Acid SCHEMBL4153840 0.85 PIM1 (0.44) PIM1KDM4EALDH1A1HSD17B10MAPT
Propionic Acid SCHEMBL4159927 0.82 ALDH1A1 (0.40) PIM1KDM4EALDH1A1MAPTMEN1
Propionic Acid SCHEMBL4155437 0.82 PPARG (0.46) KDM4EALDH1A1HSD17B10MAPTPARP1
Propionic Acid SCHEMBL4165393 0.81 IP6K1 (0.43) PIM1KDM4EALDH1A1MAPTPARP1
Propionic Acid SCHEMBL4162079 0.81 PLA2G1B (0.39) PIM1PIM3KDM4EALDH1A1MAPT
Propionic Acid SCHEMBL4160296 0.81 GRM5 (0.44) PIM1MAPTPARP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PIM1 279/4885PIM3 337/4885KDM4E 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.